No headlines found.
No press releases found.
No news found.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
China Sxt Pharmaceuticals trades on the NASDAQ stock market under the symbol SXTC.
As of December 19, 2025, SXTC stock price climbed to $1.61 with 20,114 million shares trading.
SXTC has a beta of -0.65, meaning it tends to be less sensitive to market movements. SXTC has a correlation of 0.00 to the broad based SPY ETF.
SXTC has a market cap of $186.80 million. This is considered a Micro Cap stock.
In the last 3 years, SXTC traded as high as $17.00 and as low as $.30.
The top ETF exchange traded funds that SXTC belongs to (by Net Assets): PGJ.
SXTC has outperformed the market in the last year with a price return of +380.6% while the SPY ETF gained +17.3%. However, in the short term, SXTC had mixed performance relative to the market. It has underperformed in the last 3 months, returning -15.3% vs +3.3% return in SPY. But in the last 2 weeks, SXTC shares have fared better than the market returning +12.6% compared to SPY -0.6%.
SXTC support price is $1.45 and resistance is $1.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SXTC shares will trade within this expected range on the day.
